Sensitization of Glycoengineered Interferon-β1a-Resistant Cancer Cells by cFLIP Inhibition for Enhanced Anti-Cancer Therapy
Oncotarget - United States
doi 10.18632/oncotarget.14573
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 10, 2017
Authors
Publisher
Impact Journals, LLC